Back to search

Article

Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by Aβ oligomers

2023-10-30

Abstract excerpt

<h4>ABSTRACT</h4> Inhibitors of histone deacetylases (iHDACs) are promising drugs for neurodegenerative diseases. We have evaluated the therapeutic potential of the new iHDAC6 LASSBio-1911 in Aβ oligomer (AβO) toxicity models and astrocytes, key players in neuroinflammation and Alzheimer’s disease (AD). Astrocyte phenotype and synapse density were evaluated by flow cytometry, Western blotting, immunofluorescence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b731169-e06a-57d8-a69f-6d3ccc832a20
DOI
10.1101/2023.10.25.564038
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by Aβ oligomersDOI 10.1101/2023.10.25.564038
Select a neighboring publication to make it the new centre.